Education, study and knowledge

Iproniazide: uses and side effects of this psychoactive drug

Depression is a mental health problem that has accompanied human beings throughout history. Already in ancient Greece, melancholy was spoken of as a disease with characteristics similar to what we would today consider depression, with a sad and anhedonic state of mind. Being also currently one of the most prevalent disorders worldwide, the search for a effective treatment has generated great interest over time and has become an increasingly necessary pressing.

There are various methods used to treat this condition, including psychopharmacology. One of the first drugs to be found and synthesized was iproniazide., which we will talk about throughout this article.

  • Related article: "Types of psychoactive drugs: uses and side effects"

Iproniazide: the first MAOI

Iproniazide is a psychotropic drug classified as an antidepressant that also has great historical importance. And it is that it is one of the first antidepressants synthesized, along with substances such as imipramine.

Its discovery was actually accidental, by serendipity

instagram story viewer
, since its synthesis was aimed at finding a drug that was effective against tuberculosis. In trials with tuberculosis patients, it was found to have a mood-elevating effect, something that time would be analyzed and applied to the population with depressive disorders (specifically, its use would be approved in 1958).

This medicine belongs to the group of monoamine oxidase inhibitors or MAOIs, which affect the nervous system by blocking the metabolism of certain neurotransmitters. Iproniazide is in factthe first of the MAOIs marketed and it was, along with other substances derived from it, one of the treatments of choice for patients with depression. Its action occurs in a non-specific and irreversible way, with its effects continuing for at least fifteen days.

At the level of effects, its application generates an increase in mood and activation, being effective in the treatment of depressive symptoms and reducing the inactivity and passivity of those who uses.

However, the observation of the existence of strong side effects that put the health of those who consumed it at risk, among which severe liver problems and promotion of arterial hypertension to dangerous levels, and the generation of new drugs that do not pose as much risk have meant that MAOIs, and especially the first or classic ones, are displaced and used only when other drugs fail. In the case of the iproniazide in question, it is currently no longer on the market since it is highly dangerous in terms of toxicity, and can only be found in some countries.

  • You may be interested in: "Are there different types of depression?"

Mechanism of action

Iproniazide is, as we have said, a non-selective irreversible monoamine oxidase inhibitor or MAOI. As an MAOI, it exerts its effects at the brain level by inhibiting an enzyme, MAO, whose main function is to degrade monoamines through oxidation in order to remove excess neurotransmitters generated by monoaminergic neurons (which are those that generate dopamine, noradrenaline and serotonin) in the synaptic space as well as tyramine.

Thus, inhibiting monoamine oxidase would not produce said destruction of monoamines, with which the levels of serotonin, norepinephrine and dopamine will increase in the brain. The action of iproniazide, then, would be fundamentally agonistic with respect to monoamines, favoring their action. This will generate an improvement in depressive symptoms. by increasing neurotransmitters that are decreased in major depression.

Keep in mind that there are two types of monoamine oxidase: MAO A and MAO B. The first is linked to and is responsible for metabolizing and destroying excess noradrenaline, serotonin and tyramine, the first two being the substances most linked to depression. MAO B does the same with dopamine, also influencing tyramine as before.

The fact that it is considered irreversible and non-selective implies that iproniazide acts on all types of MAO, such that it is not only that monoamine oxidase is reduced but it is completely destroyed from our brain until it synthesizes more (something that can take around fifteen days). But the truth is that the enzyme in question is useful to the brain, and the increase in neurotransmitters it generates (especially in the case of tyramine and norepinephrine) can have dangerous effects on the health.

Main indications

Iproniazide is a drug that is not currently marketed due to the high level of risk it poses to level of toxicity at the liver level and the existence of much safer drugs with fewer side effects.

However, the main indication for this drug was in cases of major depression, being effective in the treatment of symptoms at the level of mood (which contributed to increase) and anhedonia and feeling of fatigue. Likewise, it has also occasionally been used for the purpose for which it was actually initially intended: the treatment of tuberculosis.

Side effects, contraindications and risks

Iproniazide is a drug that is very useful in the treatment of depressive symptoms, but that As we have mentioned, it has been withdrawn from the market due to its high level of risk and the side effects it has. In this sense, some of the best-known side effects of iproniazide, which in fact it shares with some other MAOIs, are the following.

In the first place and one of the main reasons for its withdrawal is the high level of toxicity that this drug can have for the liver. Likewise, another of the possible side effects with the greatest risk is the appearance of severe hypertensive crises due to its interaction with a large number of number of foods rich in protein, which can even contribute to the appearance of strokes or potential heart and vascular problems mortal.

It can also cause kidney problems. Other less serious symptoms are the appearance of insomnia, weight gain and difficulties or inability to reach orgasm, delayed ejaculation or decreased libido.

All this means that there are certain types of population that have this medication totally contraindicated. In this sense, all those people who suffer from some type of pathology or liver damage stand out, as well as those with heart disease or kidney problems. People who require a hyperproteic diet also have it highly contraindicated. People with diabetes and celiac disease should not take this drug either. Iproniazide and other MAOIs have a high level of interaction with other drugs, and their use with other antidepressants and other drugs is also contraindicated.

Perphenazine: uses and side effects of this antipsychotic

One of the best-known types of mental disorder is that of psychotic disorders. This type of disor...

Read more

Rubifen (psychopharmaceutical): what it is, what it is used for and side effects

Today a large part of the population knows or has heard of the attention deficit hyperactivity di...

Read more

Pimavanserin (Antipsychotic): Indications, Uses, and Side Effects

Psychotic symptoms appear not only in psychotic disorders such as schizophrenia or delusional dis...

Read more

instagram viewer